UnknownPhase 3NCT04583410

Efficacy of Nicotine in Preventing COVID-19 Infection

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Zahir AMOURA, MD
Assistance Publique - Hôpitaux de Paris
Intervention
Nicotine patch(drug)
Enrollment
1633 target
Eligibility
18 years · All sexes
Timeline
20202022

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04583410 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials